US Stock MarketDetailed Quotes

CADL Candel Therapeutics

Watchlist
  • 1.580
  • +0.040+2.60%
Close Mar 28 16:00 ET
  • 1.750
  • +0.170+10.76%
Post 19:59 ET
46.37MMarket Cap-1206P/E (TTM)

Candel Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
Total revenue
0
0
0
0.00%125K
0.00%31K
0.00%31K
0.00%31K
0.00%31K
0.00%125K
0.00%31K
Operating revenue
--0
--0
--0
0.00%125K
0.00%31K
0.00%31K
0.00%31K
0.00%31K
0.00%125K
0.00%31K
Cost of revenue
Gross profit
Operating expense
-0.71%8.85M
8.91%9.57M
6.70%9.62M
40.46%34.8M
6.06%8.08M
12.40%8.91M
85.83%8.78M
100.51%9.02M
86.12%24.78M
26.93%7.62M
Selling and administrative expenses
-14.71%3.02M
-3.11%3.65M
15.67%4.16M
31.73%14.06M
-19.33%3.16M
26.51%3.54M
84.41%3.76M
86.05%3.6M
106.00%10.67M
49.39%3.92M
-General and administrative expense
-14.71%3.02M
-3.11%3.65M
15.67%4.16M
31.73%14.06M
-19.33%3.16M
26.51%3.54M
84.41%3.76M
86.05%3.6M
106.00%10.67M
49.39%3.92M
Research and development costs
8.72%5.85M
18.16%5.93M
0.96%5.47M
36.95%20.79M
29.01%4.97M
2.11%5.38M
52.55%5.02M
96.77%5.42M
73.38%15.18M
9.05%3.85M
Other operating expenses
---12K
---12K
---12K
95.54%-48K
----
----
----
----
-72.44%-1.08M
1.32%-149K
Operating profit
0.36%-8.85M
-9.30%-9.57M
-7.07%-9.62M
-40.67%-34.67M
-6.09%-8.05M
-12.45%-8.88M
-86.39%-8.75M
-101.21%-8.99M
-86.94%-24.65M
-27.07%-7.59M
Net non-operating interest income expense
5.11%-167K
47.67%-191K
158.29%102K
-824.53%-490K
2,154.55%226K
-1,157.14%-176K
-2,333.33%-365K
-1,358.33%-175K
-147.75%-53K
-122.45%-11K
Non-operating interest income
46.36%502K
547.14%453K
----
----
----
--343K
--70K
----
----
----
Non-operating interest expense
28.90%669K
48.05%644K
----
----
----
--519K
--435K
----
----
----
Total other finance cost
----
----
-158.29%-102K
824.53%490K
----
----
----
--175K
--53K
--11K
Other net income (expense)
57.45%581K
-97.10%144K
-91.26%724K
243.33%16.37M
-70.17%2.74M
104.47%369K
140.17%4.97M
8.29M
-148.01%-11.42M
302.02%9.2M
Gain on sale of security
57.45%581K
-97.10%144K
-91.26%724K
243.33%16.37M
-70.17%2.74M
104.47%369K
140.17%4.97M
--8.29M
-148.01%-11.42M
302.02%9.2M
Income before tax
2.91%-8.44M
-131.72%-9.61M
-906.29%-8.8M
47.97%-18.79M
-418.48%-5.08M
46.24%-8.69M
75.71%-4.15M
80.48%-874K
-104.32%-36.12M
115.23%1.6M
Income tax
Net income
2.91%-8.44M
-131.72%-9.61M
-906.29%-8.8M
47.97%-18.79M
-418.48%-5.08M
46.24%-8.69M
75.71%-4.15M
80.48%-874K
-104.32%-36.12M
115.23%1.6M
Net income continuous Operations
2.91%-8.44M
-131.72%-9.61M
-906.29%-8.8M
47.97%-18.79M
-418.48%-5.08M
46.24%-8.69M
75.71%-4.15M
80.48%-874K
-104.32%-36.12M
115.23%1.6M
Minority interest income
Net income attributable to the parent company
2.91%-8.44M
-131.72%-9.61M
-906.29%-8.8M
47.97%-18.79M
-418.48%-5.08M
46.24%-8.69M
75.71%-4.15M
80.48%-874K
-104.32%-36.12M
115.23%1.6M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
2.91%-8.44M
-131.72%-9.61M
-906.29%-8.8M
47.97%-18.79M
-418.48%-5.08M
46.24%-8.69M
75.71%-4.15M
80.48%-874K
-104.32%-36.12M
115.23%1.6M
Basic earnings per share
3.33%-0.29
-135.71%-0.33
-900.00%-0.3
65.97%-0.65
-423.57%-0.18
56.52%-0.3
79.67%-0.14
87.46%-0.03
-102.17%-1.91
109.94%0.0556
Diluted earnings per share
3.33%-0.29
-135.71%-0.33
-900.00%-0.3
65.97%-0.65
-423.57%-0.18
56.52%-0.3
79.67%-0.14
87.46%-0.03
-102.17%-1.91
109.94%0.0556
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021
Total revenue 0000.00%125K0.00%31K0.00%31K0.00%31K0.00%31K0.00%125K0.00%31K
Operating revenue --0--0--00.00%125K0.00%31K0.00%31K0.00%31K0.00%31K0.00%125K0.00%31K
Cost of revenue
Gross profit
Operating expense -0.71%8.85M8.91%9.57M6.70%9.62M40.46%34.8M6.06%8.08M12.40%8.91M85.83%8.78M100.51%9.02M86.12%24.78M26.93%7.62M
Selling and administrative expenses -14.71%3.02M-3.11%3.65M15.67%4.16M31.73%14.06M-19.33%3.16M26.51%3.54M84.41%3.76M86.05%3.6M106.00%10.67M49.39%3.92M
-General and administrative expense -14.71%3.02M-3.11%3.65M15.67%4.16M31.73%14.06M-19.33%3.16M26.51%3.54M84.41%3.76M86.05%3.6M106.00%10.67M49.39%3.92M
Research and development costs 8.72%5.85M18.16%5.93M0.96%5.47M36.95%20.79M29.01%4.97M2.11%5.38M52.55%5.02M96.77%5.42M73.38%15.18M9.05%3.85M
Other operating expenses ---12K---12K---12K95.54%-48K-----------------72.44%-1.08M1.32%-149K
Operating profit 0.36%-8.85M-9.30%-9.57M-7.07%-9.62M-40.67%-34.67M-6.09%-8.05M-12.45%-8.88M-86.39%-8.75M-101.21%-8.99M-86.94%-24.65M-27.07%-7.59M
Net non-operating interest income expense 5.11%-167K47.67%-191K158.29%102K-824.53%-490K2,154.55%226K-1,157.14%-176K-2,333.33%-365K-1,358.33%-175K-147.75%-53K-122.45%-11K
Non-operating interest income 46.36%502K547.14%453K--------------343K--70K------------
Non-operating interest expense 28.90%669K48.05%644K--------------519K--435K------------
Total other finance cost ---------158.29%-102K824.53%490K--------------175K--53K--11K
Other net income (expense) 57.45%581K-97.10%144K-91.26%724K243.33%16.37M-70.17%2.74M104.47%369K140.17%4.97M8.29M-148.01%-11.42M302.02%9.2M
Gain on sale of security 57.45%581K-97.10%144K-91.26%724K243.33%16.37M-70.17%2.74M104.47%369K140.17%4.97M--8.29M-148.01%-11.42M302.02%9.2M
Income before tax 2.91%-8.44M-131.72%-9.61M-906.29%-8.8M47.97%-18.79M-418.48%-5.08M46.24%-8.69M75.71%-4.15M80.48%-874K-104.32%-36.12M115.23%1.6M
Income tax
Net income 2.91%-8.44M-131.72%-9.61M-906.29%-8.8M47.97%-18.79M-418.48%-5.08M46.24%-8.69M75.71%-4.15M80.48%-874K-104.32%-36.12M115.23%1.6M
Net income continuous Operations 2.91%-8.44M-131.72%-9.61M-906.29%-8.8M47.97%-18.79M-418.48%-5.08M46.24%-8.69M75.71%-4.15M80.48%-874K-104.32%-36.12M115.23%1.6M
Minority interest income
Net income attributable to the parent company 2.91%-8.44M-131.72%-9.61M-906.29%-8.8M47.97%-18.79M-418.48%-5.08M46.24%-8.69M75.71%-4.15M80.48%-874K-104.32%-36.12M115.23%1.6M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 2.91%-8.44M-131.72%-9.61M-906.29%-8.8M47.97%-18.79M-418.48%-5.08M46.24%-8.69M75.71%-4.15M80.48%-874K-104.32%-36.12M115.23%1.6M
Basic earnings per share 3.33%-0.29-135.71%-0.33-900.00%-0.365.97%-0.65-423.57%-0.1856.52%-0.379.67%-0.1487.46%-0.03-102.17%-1.91109.94%0.0556
Diluted earnings per share 3.33%-0.29-135.71%-0.33-900.00%-0.365.97%-0.65-423.57%-0.1856.52%-0.379.67%-0.1487.46%-0.03-102.17%-1.91109.94%0.0556
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg